OverviewSuggest Edit

    Oncolinx is a company developing antibody-drug conjugates (ADCs). They carry an azonafide cytotoxin attached to an antibody to tumor cells, avoiding side effects associated with traditional forms of chemotherapy. It induces cancer cell death and activates the immune system through immunogenic cell death (ICD).

    Latest Updates

    Employees (est.) (Mar 2020)4

    Oncolinx Financials and Metrics

    Summary Metrics

    Founding Date

    Show all financial metrics

    Oncolinx Online and Social Media Presence

    Embed Graph

    Oncolinx Frequently Asked Questions

    • When was Oncolinx founded?

      Oncolinx was founded in 2013.

    • How many employees does Oncolinx have?

      Oncolinx has 4 employees.

    • Who are Oncolinx competitors?

      Competitors of Oncolinx include HEPHAISTOS-Pharma, Turnstone Biologics and Oncolead.